openPR Logo
Press release

Carotid Stent Market Size, Share, Trends, Growth and Forecast Report 2023-2030

10-20-2023 11:57 AM CET | Health & Medicine

Press release from: DataM Intelligence

DataM Intelligence

DataM Intelligence

The Carotid Stent Market is expected to grow at a CAGR of 7.2% during the forecast period 2023-2030. North America region has the highest market share in the Carotid Stent Market, and it is further continuing its dominance during the forecast period.

Browse Full Report at: https://www.datamintelligence.com/research-report/carotid-stent-market

Our research report gives wide perceptions of the latest trends and development prospects of the market analysis, detailed segmentation analysis, volume, size, share, growth drives, and opportunities in the market. In-depth regional and country-level illustration of the competitive landscape depends on several phases and status of clinical trials over the prominent economies of the globe, and also report contains a number of major companies profiled in the relevant market.

Market Drivers:
For an impressive time frame, stents have been utilized as a piece of coronary and fringe systems in numerous nations to keep away from or kill the limiting and thwarting of vessels. The usage of these stents has been compelling; they are not without disadvantages and concerns. Restenosis, or the reoccurrence of vessel restricting after the interventional system, is a commonplace side effect of a body's typical response to an unfamiliar molecule in the vasculature. The medication eluting stents (DES) bring about better clinical results by diminishing the gamble of restenosis altogether. New enhancements in DES, like biodegradable and bifurcated stents, are expected to expand the market worth of an organization. Associations like Biosensors and Abbott make biodegradable and bifurcated stents to oversee issues of apoplexy, which is brought about by long haul gadget implantation.

The interest for insignificantly obtrusive methodology has been quickly expanding all around the world. MI methodology diminishes the actual injury risk and the possibilities of a disease, in this manner empowering patients to have a more helpful and faster recuperation. MI methods enjoy specific benefits, for example, reasonable expense and more limited emergency clinic stays. These techniques have shown improved results than customary strategies.

Download Sample Report at: https://www.datamintelligence.com/download-sample/carotid-stent-market

Market Segmentation:

By Material
By Type
By Region

Major Companies Covered:
Abbott Laboratories, Cardinal Health, Medtronic Plc, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, BIOTRONIK SE & Co. KG, InspireMD, Impulse Dynamics, Shanghai Hengfei Biological Technology Co., Ltd, Beijing Bomais Technology Development, Shanghai Zhenyu Biological Technology Co., Ltd, and Shanghai Haoran Biotechnology Co., Ltd.

Trending Topics:
Colonic Stents Market: https://www.datamintelligence.com/research-report/colonic-stents-market
Aortic Stents Grafts Market: https://www.datamintelligence.com/research-report/aortic-stents-grafts-market
Biliary Stents Market: https://www.datamintelligence.com/research-report/biliary-stents-market

DataM Intelligence 4market Research LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039.

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carotid Stent Market Size, Share, Trends, Growth and Forecast Report 2023-2030 here

News-ID: 3258193 • Views:

More Releases from DataM Intelligence

U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6.3% CAGR Driven by Advances in Nuclear Medicine and Theranostics
U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6 …
The United States radiopharmaceuticals market was valued at USD 2.21 billion in 2024 and is projected to reach USD 2.36 billion by 2033, exhibiting a CAGR of 6.3% during the forecast period, according to DataM Intelligence. The market expansion is primarily fueled by the growing prevalence of chronic diseases such as cancer and cardiovascular disorders, advancements in diagnostic imaging, and regulatory support for nuclear medicine infrastructure. Radiopharmaceuticals play a pivotal
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR Driven by Demand for Natural and Innovative Taste Solutions
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR …
The U.S. flavors market was valued at USD 3,887.7 million in 2024 and is projected to reach USD 6,108.4 million by 2033, growing at a CAGR of 5.2% during 2025-2033, according to DataM Intelligence. The market's growth is driven by surging demand for processed foods, global flavor innovation, and increasing consumer preference for natural, clean-label, and wellness-oriented products. Flavors continue to play a vital role in enhancing the sensory experience
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% CAGR Amid Rising Animal Nutrition Investments
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% …
The Europe Feed Premix Market is estimated to grow from USD 5.92 billion in 2025 to USD 7.31 billion by 2030, registering a CAGR of 4.32% during the forecast period, according to DataM Intelligence. The market's growth is driven by increasing demand for nutrient-rich animal feed formulations, expanding livestock production, and a rising preference for high-quality, antibiotic-free animal products. Feed premixes-comprising essential vitamins, minerals, amino acids, and other additives-are vital
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growing at a 5.5% CAGR on Rising Demand for Natural Additives
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growin …
The North America Feed Phytogenics Market is projected to grow from USD 383.10 million in 2025 to USD 500.60 million by 2030, at a CAGR of 5.5% during the forecast period, according to DataM Intelligence. The market is witnessing robust growth due to rising demand for high-quality animal-derived products and increasing regulatory restrictions on antibiotics in livestock production. As a result, plant-based feed solutions have gained widespread adoption for improving

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients